Both in Pharmaceuticals

Nexentis Technologies vs Matinas BioPharma Holdings

Over the past year NXTS returned −92.3% and MTNB returned −85.8%; their daily moves had a correlation of 0.29.

NXTS −92.3% MTNB −85.8%Growth of $1, one year, split-adjusted
MetricNXTSMTNB
Price$0.5556$1.29
Market cap$807.5K$1.3M
Today−5.07%−14.90%
1 month−62.7%−51.3%
6 months—−87.2%
Year to date—−85.4%
1 year—−93.7%
Revenue growth (YoY)——
Gross margin——
Net margin——
P/E (TTM)——
Price / sales——
Net cash$8.5M$755.0K
Dividend yield——
Volatility (60d)—775.4%
Short % of float2.5%0.5%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).